The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antihistamine Drugs-Global Market Insights and Sales Trends 2024

Antihistamine Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1835897

No of Pages : 105

Synopsis
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response.
The global Antihistamine Drugs market size is expected to reach US$ 292.8 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Antihistamine Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Antihistamine Drugs market. Prescription-based Antihistamine Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Over-the-counter(OTC) Antihistamine Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antihistamine Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antihistamine Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antihistamine Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antihistamine Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antihistamine Drugs covered in this report include Bayer, Almirall, Meda Consumer Healthcare, AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Pfizer and Boehringer Ingelheim, etc.
The global Antihistamine Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Almirall
Meda Consumer Healthcare
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Pfizer
Boehringer Ingelheim
Akorn
Merck & Co.
Teva Pharmaceutical
Global Antihistamine Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antihistamine Drugs market, Segment by Type:
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Global Antihistamine Drugs market, by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antihistamine Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antihistamine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Sale Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Antihistamine Drugs Market Overview
1.1 Antihistamine Drugs Product Overview
1.2 Antihistamine Drugs Market Segment by Type
1.2.1 Prescription-based Antihistamine Drugs
1.2.2 Over-the-counter(OTC) Antihistamine Drugs
1.3 Global Antihistamine Drugs Market Size by Type
1.3.1 Global Antihistamine Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antihistamine Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antihistamine Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antihistamine Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antihistamine Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antihistamine Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antihistamine Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antihistamine Drugs Sales Breakdown by Type (2018-2023)
2 Global Antihistamine Drugs Market Competition by Company
2.1 Global Top Players by Antihistamine Drugs Sales (2018-2023)
2.2 Global Top Players by Antihistamine Drugs Revenue (2018-2023)
2.3 Global Top Players by Antihistamine Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antihistamine Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antihistamine Drugs Market Competitive Situation and Trends
2.5.1 Antihistamine Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antihistamine Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antihistamine Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antihistamine Drugs Market
2.8 Key Manufacturers Antihistamine Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antihistamine Drugs Status and Outlook by Region
3.1 Global Antihistamine Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antihistamine Drugs Historic Market Size by Region
3.2.1 Global Antihistamine Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antihistamine Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antihistamine Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antihistamine Drugs Forecasted Market Size by Region
3.3.1 Global Antihistamine Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antihistamine Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antihistamine Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antihistamine Drugs by Sale Channel
4.1 Antihistamine Drugs Market Segment by Sale Channel
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Antihistamine Drugs Market Size by Sale Channel
4.2.1 Global Antihistamine Drugs Market Size Overview by Sale Channel (2018-2029)
4.2.2 Global Antihistamine Drugs Historic Market Size Review by Sale Channel (2018-2023)
4.2.3 Global Antihistamine Drugs Forecasted Market Size by Sale Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sale Channel
4.3.1 North America Antihistamine Drugs Sales Breakdown by Sale Channel (2018-2023)
4.3.2 Europe Antihistamine Drugs Sales Breakdown by Sale Channel (2018-2023)
4.3.3 Asia-Pacific Antihistamine Drugs Sales Breakdown by Sale Channel (2018-2023)
4.3.4 Latin America Antihistamine Drugs Sales Breakdown by Sale Channel (2018-2023)
4.3.5 Middle East and Africa Antihistamine Drugs Sales Breakdown by Sale Channel (2018-2023)
5 North America Antihistamine Drugs by Country
5.1 North America Antihistamine Drugs Historic Market Size by Country
5.1.1 North America Antihistamine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antihistamine Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antihistamine Drugs Sales in Value by Country (2018-2023)
5.2 North America Antihistamine Drugs Forecasted Market Size by Country
5.2.1 North America Antihistamine Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antihistamine Drugs Sales in Value by Country (2024-2029)
6 Europe Antihistamine Drugs by Country
6.1 Europe Antihistamine Drugs Historic Market Size by Country
6.1.1 Europe Antihistamine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antihistamine Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antihistamine Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antihistamine Drugs Forecasted Market Size by Country
6.2.1 Europe Antihistamine Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antihistamine Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antihistamine Drugs by Region
7.1 Asia-Pacific Antihistamine Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antihistamine Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antihistamine Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antihistamine Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antihistamine Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antihistamine Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antihistamine Drugs Sales in Value by Region (2024-2029)
8 Latin America Antihistamine Drugs by Country
8.1 Latin America Antihistamine Drugs Historic Market Size by Country
8.1.1 Latin America Antihistamine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antihistamine Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antihistamine Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antihistamine Drugs Forecasted Market Size by Country
8.2.1 Latin America Antihistamine Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antihistamine Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antihistamine Drugs by Country
9.1 Middle East and Africa Antihistamine Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antihistamine Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antihistamine Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antihistamine Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antihistamine Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antihistamine Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antihistamine Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Antihistamine Drugs Products Offered
10.1.5 Bayer Recent Development
10.2 Almirall
10.2.1 Almirall Company Information
10.2.2 Almirall Introduction and Business Overview
10.2.3 Almirall Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Almirall Antihistamine Drugs Products Offered
10.2.5 Almirall Recent Development
10.3 Meda Consumer Healthcare
10.3.1 Meda Consumer Healthcare Company Information
10.3.2 Meda Consumer Healthcare Introduction and Business Overview
10.3.3 Meda Consumer Healthcare Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Meda Consumer Healthcare Antihistamine Drugs Products Offered
10.3.5 Meda Consumer Healthcare Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Antihistamine Drugs Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson Antihistamine Drugs Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Antihistamine Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi Antihistamine Drugs Products Offered
10.7.5 Sanofi Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Antihistamine Drugs Products Offered
10.8.5 Pfizer Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Information
10.9.2 Boehringer Ingelheim Introduction and Business Overview
10.9.3 Boehringer Ingelheim Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Boehringer Ingelheim Antihistamine Drugs Products Offered
10.9.5 Boehringer Ingelheim Recent Development
10.10 Akorn
10.10.1 Akorn Company Information
10.10.2 Akorn Introduction and Business Overview
10.10.3 Akorn Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Akorn Antihistamine Drugs Products Offered
10.10.5 Akorn Recent Development
10.11 Merck & Co.
10.11.1 Merck & Co. Company Information
10.11.2 Merck & Co. Introduction and Business Overview
10.11.3 Merck & Co. Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Merck & Co. Antihistamine Drugs Products Offered
10.11.5 Merck & Co. Recent Development
10.12 Teva Pharmaceutical
10.12.1 Teva Pharmaceutical Company Information
10.12.2 Teva Pharmaceutical Introduction and Business Overview
10.12.3 Teva Pharmaceutical Antihistamine Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Teva Pharmaceutical Antihistamine Drugs Products Offered
10.12.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antihistamine Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antihistamine Drugs Industrial Chain Analysis
11.4 Antihistamine Drugs Market Dynamics
11.4.1 Antihistamine Drugs Industry Trends
11.4.2 Antihistamine Drugs Market Drivers
11.4.3 Antihistamine Drugs Market Challenges
11.4.4 Antihistamine Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antihistamine Drugs Distributors
12.3 Antihistamine Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’